![Kenneth Kovan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth Kovan
Gründer bei
BIOVAXYS TECHNOLOGY CORP.
Vermögen: 102 881 $ am 31.07.2026
Profil
Kenneth E.
Kovan is the founder of AVAX Technologies, Inc., founded in 1990.
Mr. Kovan is the founder of Bingham Hill Ventures, founded in 2012, holding the title of Managing Principal.
Mr. Kovan is also the founder of BioVaxys Technology Corp.,BioVaxys LLC.
Mr. Kovan is currently the President of Chaperone Technologies, Inc. Former positions include Principal at Thomas Jefferson University, Principal at GSK Plc, Principal at Wyeth-Ayerst Research, and Partner at Revvity Discovery Ltd.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.10.2025 | 935’286 ( 3.21% ) | 102 881 $ | 31.07.2026 |
Aktive Positionen von Kenneth Kovan
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOVAXYS TECHNOLOGY CORP. | Gründer | - |
Chaperone Technologies, Inc.
 Chaperone Technologies, Inc. Medical SpecialtiesHealth Technology Develops novel products for infectious diseases | Präsident | - |
BioVaxys LLC
 BioVaxys LLC BiotechnologyHealth Technology Develops viral oncology and therapeutic platforms | Gründer | - |
Bingham Hill Ventures | Gründer | 01.01.2012 |
Ehemalige bekannte Positionen von Kenneth Kovan
| Unternehmen | Position | Ende |
|---|---|---|
Horizon Discovery Ltd.
 Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and supplying patient-relevant drug discovery and diagnostic research tools | Corporate Officer/Principal | - |
Wyeth-Ayerst Research | Corporate Officer/Principal | - |
| GSK PLC | Corporate Officer/Principal | - |
Thomas Jefferson University
 Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| AVAX TECHNOLOGIES, INC. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
10
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
AVAX Technologies, Inc.
 AVAX Technologies, Inc. BiotechnologyHealth Technology Operates as development stage company with interest in the development and future commercialization of individualized cancer vaccines | Health Technology |
Thomas Jefferson University
Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Wyeth-Ayerst Research | |
Chaperone Technologies, Inc.
Chaperone Technologies, Inc. Medical SpecialtiesHealth Technology Develops novel products for infectious diseases | Health Technology |
Horizon Discovery Ltd.
Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and supplying patient-relevant drug discovery and diagnostic research tools | Commercial Services |
BioVaxys Technology Corp.
 BioVaxys Technology Corp. Other Metals/MineralsNon-Energy Minerals Provides mining exploration services | Non-Energy Minerals |
BioVaxys LLC
BioVaxys LLC BiotechnologyHealth Technology Develops viral oncology and therapeutic platforms | Health Technology |
Bingham Hill Ventures |
